- Home
- DNTH vs WERN Comparison
DNTH vs WERN Comparison
Compare DNTH & WERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- WERN
- Stock Information
- Founded
- DNTH 2015
- WERN 1956
- Country
- DNTH United States
- WERN United States
- Employees
- DNTH N/A
- WERN N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- WERN Trucking Freight/Courier Services
- Sector
- DNTH Health Care
- WERN Industrials
- Exchange
- DNTH Nasdaq
- WERN Nasdaq
- Market Cap
- DNTH 1.4B
- WERN 1.6B
- IPO Year
- DNTH N/A
- WERN N/A
- Fundamental
- Price
- DNTH $33.67
- WERN $26.45
- Analyst Decision
- DNTH Strong Buy
- WERN Hold
- Analyst Count
- DNTH 11
- WERN 13
- Target Price
- DNTH $65.22
- WERN $26.62
- AVG Volume (30 Days)
- DNTH 516.1K
- WERN 1.7M
- Earning Date
- DNTH 11-07-2025
- WERN 10-30-2025
- Dividend Yield
- DNTH N/A
- WERN 2.13%
- EPS Growth
- DNTH N/A
- WERN N/A
- EPS
- DNTH N/A
- WERN 0.41
- Revenue
- DNTH $4,854,000.00
- WERN $2,991,440,000.00
- Revenue This Year
- DNTH N/A
- WERN $1.34
- Revenue Next Year
- DNTH N/A
- WERN $5.21
- P/E Ratio
- DNTH N/A
- WERN $63.78
- Revenue Growth
- DNTH 17.87
- WERN N/A
- 52 Week Low
- DNTH $13.37
- WERN $23.02
- 52 Week High
- DNTH $40.16
- WERN $42.48
- Technical
- Relative Strength Index (RSI)
- DNTH 46.99
- WERN 45.85
- Support Level
- DNTH $32.28
- WERN $23.50
- Resistance Level
- DNTH $35.40
- WERN $27.87
- Average True Range (ATR)
- DNTH 1.59
- WERN 1.00
- MACD
- DNTH -0.20
- WERN -0.14
- Stochastic Oscillator
- DNTH 26.53
- WERN 51.85
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About WERN Werner Enterprises Inc.
Werner Enterprises Inc is a transportation and logistics company. The company has two reportable segments - Truckload Transportation Services and Werner Logistics. It derives majority of its revenue from full-truckload transportation services and geographically from United States.